| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. | J Natl Cancer Inst | 2003 | 3.77 |
| 2 | Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. | Int J Cancer | 2006 | 1.04 |
| 3 | Asymmetries in the spatial distributions of enhancing lesions and black holes in relapsing-remitting MS. | J Clin Neurosci | 2005 | 0.76 |